[1]Schwartz AM,Farley KX,Guild GN,et al.Projections and epidemiology of revision hip and knee arthroplasty in the United States to 2030[J].J Arthroplasty,2020,35(6s):S79-S85.
[2]Pupaibool J,Fulnecky EJ,Swords RL,et al.Alpha-defensin-novel synovial fluid biomarker for the diagnosis of periprosthetic joint infection[J].Int Orthop,2016,40(12):2447-2452.
[3]Marazzi MG,Randelli F,Brioschi M,et al.Presepsin:A potential biomarker of PJI? A comparative analysis with known and new infection biomarkers[J].Int J Immunopathol Pharmacol,2018 (31):394632017749356.
[4]Hozack WJ,Parvizi J.New definition for periprosthetic joint infection[J].J Arthroplasty,2011,26(8):1135.
[5]Parvizi J,Gehrke T,Chen AF.Proceedings of the international consensus on periprosthetic joint infection[J].Bone Joint J,2013,95(11):1450-1452.
[6]Parvizi J,Tan TL,Goswami K,et al.The 2018 definition of periprosthetic hip and knee infection:An evidence-based and validated criteria[J].J Arthroplasty,2018,33(5):1309-1314.
[7]Alijanipour P,Bakhshi H,Parvizi J.Diagnosis of periprosthetic joint infection:the threshold for serological markers[J].Clin Orthop Relat Res,2013,471(10):3186-3195.
[8]Saleh A,George J,Faour M,et al.Serum biomarkers in periprosthetic joint infections[J].Bone Joint Res,2018,7(1):85-93.
[9]McArthur BA,Abdel MP,Taunton MJ,et al.Seronegative infections in hip and knee arthroplasty:Periprosthetic infections with normal erythrocyte sedimentation rate and Creactive protein level[J].Bone Joint J,2015,97(7):939-944.
[10]Bingham JS,Hassebrock JD,Christensen AL,et al.Screening for periprosthetic joint infections with ESR and CRP:The ideal cutoffs[J].J Arthroplasty,2020,35(5):1351-1354.
[11]Elgeidi A,Elganainy AE,Abou Elkhier N,et al.Interleukin-6 and other inflammatory markers in diagnosis of periprosthetic joint infection[J].Int Orthop,2014,38(12):2591-2595.
[12]Randau TM,Friedrich MJ,Wimmer MD,et al.Interleukin-6 in serum and in synovial fluid enhances the differentiation between periprosthetic joint infection and aseptic loosening[J].PloS one,2014,9(2):e89045.
[13]Qin L,Li X,Wang J,et al.Improved diagnosis of chronic hip and knee prosthetic joint infection using combined serum and synovial IL-6 tests[J].Bone Joint Res,2020,9(9):587-592.
[14]Shahi A,Kheir MM,Tarabichi M,et al.Serum D-dimer test is promising for the diagnosis of periprosthetic joint infection and timing of reimplantation[J].J Bone Joint Surg(Am),2017,99(17):1419-1427.
[15]Li R,Shao HY,Hao LB,et al.Plasma fibrinogen exhibits better performance than plasma D-dimer in the diagnosis of periprosthetic joint infection:A multicenter retrospective study[J].J Bone Joint Surg(Am),2019,101(7):613-619.
[16]Pannu TS,Villa JM,Patel PD,et al.The utility of serum D-dimer for the diagnosis of periprosthetic joint infection in revision total hip and knee arthroplasty[J].J Arthroplasty,2020,35(6):1692-1695.
[17]Xiong L,Li S,Dai M.Comparison of D-dimer with CRP and ESR for diagnosis of periprosthetic joint infection[J].J Orthop Surg Res,2019,14(1):240.
[18]Li C,Margaryan D,Ojeda-Thies C,et al.Meta-analysis of serum and/or plasma D-dimer in the diagnosis of periprosthetic joint infection[J].J Orthop Surg Res,2020,15(1):298.
[19]Friedrich MJ,Randau TM,Wimmer MD,et al.Lipopolysaccharide-binding protein:A valuable biomarker in the differentiation between periprosthetic joint infection and aseptic loosening?[J].Int Orthop,2014,38(10):2201-2207.
[20]Ni W,Han Y,Zhao J,et al.Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults:A systematic review and metaanalysis[J].Sci Rep,2016(6):39481.
[21]Galliera E,Drago L,Marazzi MG,et al.Soluble urokinase-type plasminogen activator receptor (suPAR) as new biomarker of the prosthetic joint infection:Correlation with inflammatory cytokines[J].Clin Chim Acta,2015(441):23-28.
[22]Worthington T,Dunlop D,Casey A,et al.Serum procalcitonin,interleukin-6,soluble intercellular adhesin molecule-1 and IgG to short-chain exocellular lipoteichoic acid as predictors of infection in total joint prosthesis revision[J].Br J Biomed Sci,2010,67(2):71-76.
[23]Drago L,Vassena C,Dozio E,et al.Procalcitonin,C-reactive protein,interleukin-6,and soluble intercellular adhesion molecule-1 as markers of postoperative orthopaedic joint prosthesis infections[J].Int J Immunopathol Pharmacol,2011,24(2):433-440.
[24]Saleh A,Ramanathan D,Siqueira MBP,et al.The diagnostic utility of synovial fluid markers in periprosthetic joint infection:A systematic review and meta-analysis[J].J Am Acad Orthop Surg,2017,25(11):763-772.
[25]Lee YS,Koo KH,Kim HJ,et al.Synovial fluid biomarkers for the diagnosis of periprosthetic joint infection:A systematic review and meta-analysis[J].J Bone Joint Surg(Am),2017,99(24):2077-2084.
[26]Di Benedetto P,Dalla Vecchia G,Dante F,et al.Leukocyte esterase strip test as a reliable intraoperative PJIs biomarker.Our experience[J].Acta Biomed,2019,90(12):43-47.
[27]Li Z,Zhang Q,Shi L,et al.Alpha-defensin versus leukocyte esterase in periprosthetic joint infection:An updated meta-analysis[J].Biomed Res Int,2020(2020):3704285.
[28]Deirmengian C,Lonner JH,Booth RE,Jr.The mark coventry award:White blood cell gene expression:A new approach toward the study and diagnosis of infection[J].Clin Orthop,2005(440):38-44.
[29]Deirmengian C,Kardos K,Kilmartin P,et al.The Alpha-defensin test for periprosthetic joint infection responds to a wide spectrum of organisms[J].Clin Orthop,2015(473):2229-2235.
[30]Deirmengian C,Madigan J,Kallur Mallikarjuna S,et al.Validation of the alpha defensin lateral flow test for periprosthetic joint infection[J].J Bone Joint Surg(Am),2021,103(2):115-122.
[31]Wang C,Wang Q,Li R,et al.Synovial fluid c-reactive protein as a diagnostic marker for periprosthetic joint infection:A systematic review and meta-analysis[J].Chin Med J (Engl),2016,129(16):1987-1993.
[32]Praz C,Gubbiotti L,Buia G,et al.Value of the synovial C-reactive protein test in the diagnosis of total hip and knee periprosthetic joint infections:A case-control study[J].Orthop Traumatol Surg Res,2021,107(4):102903.
[33]Gallo J,Svoboda M,Zapletalova J,et al.Serum IL-6 in combination with synovial IL-6/CRP shows excellent diagnostic power to detect hip and knee prosthetic joint infection[J].PloS one,2018,13(6):e0199226.
[34]陈志,周宗科,沈彬,等.急性、迟发性、慢性假体周围感染的病原学特征及疗效分析[J].实用骨科杂志,2019,25(4):313316.
[35]Galliera E,Drago L,Vassena C,et al.Toll-like receptor 2 in serum:a potential diagnostic marker of prosthetic joint infection?[J].J Clin Microbiol,2014,52(2):620-623.
[36]Cipriano C,Maiti A,Hale G,et al.The host response:Toll-like receptor expression in periprosthetic tissues as a biomarker for deep joint infection[J].J Bone Joint Surg(Am),2014,96(20):1692-1698.
[37]Yin H,Xu D,Wang D.Diagnostic value of next-generation sequencing to detect periprosthetic joint infection[J].BMC Musculoskelet Disord,2021,22(1):252.
[38]Tirumala V,Klemt C,Xiong L,et al.Diagnostic utility of platelet count/lymphocyte count ratio and platelet count/mean platelet volume ratio in periprosthetic joint infection following total knee arthroplasty[J].J Arthroplasty,2021,36(1):291-297.
[39]Wang H,Zhou H,Jiang R,et al.Globulin,the albumin-to-globulin ratio,and fibrinogen perform well in the diagnosis of periprosthetic joint infection[J].BMC Musculoskelet Disord,2021,22(1):583.